Edwards Lifesciences Corp (EW)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$70.47

Buy

$75.00

arrow-down$-0.95 (-1.27%)

Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.
Prices updated at 09 May 2025, 10:38 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-down-0.07%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Nicholas J. Valeriani
CEO
Mr. Bernard J. Zovighian
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
15,800
Head office
One Edwards Way
Irvine
United States
92614
mobile
+1 949 250-2500
letter
investor_relations@edwards.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Donald E. Bobo,Jr
Corporate Vice President
0.74m0.00m-3.75m-
Mr. Kieran T. Gallahue
Independent Director
0.09m--0.35m-
Mr. Larry L. Wood
Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart
0.78m--4.61m-
Mr. Nicholas J. Valeriani
Chairman of the Board
0.09m--0.09m-
Mr. Paul A. Laviolette
Independent Director
0.11m--0.37m-
Mr. Steven R. Loranger
Independent Director
0.09m--0.35m-
Ms. Leslie Stone Heisz
Independent Director
0.12m--0.37m-
Mr. Scott B. Ullem
Corporate Vice President and Chief Financial Officer
0.77m--5.30m-
Dr. David T. Feinberg, M.D.,PhD
Director
0.08m--0.29m-
Mr. Bernard J. Zovighian
Director and Chief Executive Officer
1.13m--14.58m-
Mr. Daveen Chopra
Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies
0.63m--3.72m-
Ms. Ramona A. Sequeira
Independent Director
0.09m--0.50m-
Mr. Wayne Markowitz
General Manager and Senior Vice President, Surgical Structural Heart
-----
Ms. Annette Bruls
Corporate Vice President, EMEACLA
-----
Mr. Daniel J. Lippis
Corporate Vice President, JAPAC
-----
Ms. Leslie C. Davis
Independent Director
0.09m--0.34m-
Mr. Andrew M. Dahl
Principal Accounting Officer, Senior Vice President and Corporate Controller
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc69,132,0360.08914653749410.44419230 Apr 202511.79
Vanguard Group Inc. ( Junked)62,594,108-62594108-30 Apr 202510.61
BlackRock Inc54,520,3200.08167-64846-0.11879830 Apr 20259.29
Wellington Management Company LLP33,210,8790.4501416781545.32194430 Apr 20255.66
State Street Corp25,808,6220.07538-457011-1.73995830 Apr 20254.40

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
16 Dec 2024-Mr. Daniel J. Lippis45.28113,19225,689--
16 Dec 2024-Mr. Daniel J. Lippis--2,030--
16 Dec 2024-Mr. Daniel J. Lippis74.08185,19623,189--
09 Dec 2024-Mr. Donald E. Bobo,Jr45.28226,38451,936--
09 Dec 2024-Mr. Donald E. Bobo,Jr--30,500--
09 Dec 2024-Mr. Donald E. Bobo,Jr71.75358,75146,936--
09 Dec 2024-Mr. Scott B. Ullem--45,000--
09 Dec 2024-Mr. Scott B. Ullem71.68806,40630,561--
09 Dec 2024-Mr. Scott B. Ullem45.28509,36341,811--
06 Dec 2024-Mr. Daveen Chopra73.27128,22327,583--
06 Dec 2024-Mr. Wayne Markowitz73.2742,7169,494--
13 Nov 2024-Mr. Donald E. Bobo,Jr65.57327,84346,936--
13 Nov 2024-Mr. Donald E. Bobo,Jr--35,500--
13 Nov 2024-Mr. Donald E. Bobo,Jr45.28226,38451,936--
05 Nov 2024-Mr. Larry L. Wood65.911,647,863198,526--
15 Oct 2024-Mr. Donald E. Bobo,Jr69.51347,53446,936--
15 Oct 2024-Mr. Donald E. Bobo,Jr--40,500--
15 Oct 2024-Mr. Donald E. Bobo,Jr45.28226,38451,936--
14 Sep 2024-Mr. Wayne Markowitz68.5244,40110,033--
13 Sep 2024-Mr. Andrew M. Dahl--4,691--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.